top of page

Values in Rs. in  Crores

PIRAMAL PHARMA Sep 23 Year on Year Revenue Increases by 11.1% to Rs.1911 Crore and Year on Year Profit increases sharply by 114.5% to Rs.5 Crore. Quarter to Quarter Revenue Increases by 9.3% and Q to Q Profit jumps by 105.5%

00:00 / 04:05
download (4).png

Revenue Analysis:

PIRAMAL PHARMA, has reported a revenue of Rs. 1911 Crore, which has grown by 9.3% as compared to previous quarter revenue of Rs. 1749 Crore. As compared to revenue of September-22, there is a upscales by 11.1% from Rs. 1720 Crore. to Rs. 1911 Crore.


Market Expectations V/s Actual

The Market Estimate of the Revenue was Rs.1920.6 Crore . Company's reported Revenue of Rs. 1911 is fairly in line with expectations.


Profit and Cost Analysis

Quarterly Profit has zooms by 114.5% to Rs.5 Crore from Rs. -37 Crore, when compared with year ago quarter results. In comparison with preceding quarter of June, 2023 , quarter profit has increases sharply by 105.5% to Rs.5 Crore from Rs. -99 Crore. Net Profit % of the Company has remained at 0.3% compared to -5.6% in previous quarter and -2.2% in year ago quarter.


On analysis, it is observed that this Quarter's EBITDA (Operating Profit) Margin has grown to 13.9% from 7.6% as compared with June, 2023 quarter. The reason for the rise of EBITDA Margin is due to,

a) Cost of Sales has diminish to 33.4% (Previous Quarter: 35.8%). Cost of Sales in absolute terms has upscales from Rs. 627 Crore to 638 Crore.

b) Employee Cost has shrinks to 27.0% (Previous Quarter: 28.3%). Employee Cost in exact value has increases from Rs. 496 Crore to 516 Crore.

c) Other Expenses has slip to 25.7% (Previous Quarter: 28.3%). Other Expenses nearly remain flat from Rs. 494 Crore to 492 Crore.

The finance cost has lessen from Rs. 118.52 Crore to 109.87 Crore by -7.3%.


Share Price Movement:

The Return on Share Prices were -9.3% in past one month, -9.3% in 3 months, 31.3% in 6 months, -42.9% in 12 months, NA in 24 months.


Summary:

To summarize, as compared to June'23, Revenue has increases by 9.3%. Gross Margin has increases from 64.2% to 66.6%. EBITDA Margin has grown to 13.9% from 7.6%. and Net Profit After Tax Margin has increases sharply to 0.3% from -5.6%.


The Brief of Quarterly Results is as follows:

PIRAMAL PHARMA LIMITED

Particulars (In Cr.)
Sep, 2023
Jun, 2023
Mar, 2023
Dec, 2022
Revenue
1911.4
1748.9
2163.6
1716
Cost of Goods Sold
637.7
626.7
839.7
625.3
Employee Cost
516
495.5
473.5
492.2
Other Expenses
491.6
494.3
499.1
511.1
EBITDA
266
132.3
351.3
87.3
Depreciation
184.5
173.6
184.4
164.4
Interest Expense
109.9
118.5
104.3
94.7
Other Income
68.3
52.7
32.3
98.1
Profit B4 Excep. Items
40
-107.1
94.9
-73.6
Exception Items
0
0
0
0
Net Profit Before Tax
40
-107.1
94.9
-73.6
Taxes
34.5
-8.5
44.8
16.5
Net Profit After Tax
5.4
-98.6
50.1
-90.2
Gross Margin %
66.60%
64.20%
61.20%
63.60%
Employee Cost %
27.00%
28.30%
21.90%
28.70%
Other Expense Cost %
25.70%
28.30%
23.10%
29.80%
EBITDA %
13.90%
7.60%
16.20%
5.10%
Net Profit After Tax %
0.30%
-5.60%
2.30%
-5.30%

Blue Dart Sep 23 Revenue as compared to Sep,22 Nearly Maintains by 0.1% to Rs.1324 Crore and Year on Year Profit turndowns by 22.0% to Rs.73 Crore. Quarter to Quarter Revenue Surge by 7.0% and Q to Q Profit increases sharply by 19.2%

00:00 / 03:44

Reliance Sep 23 Revenue as compared to Sep,22 Nearly Maintains by 0.9% to Rs.234956 Crore and Year on Year Profit flies by 28.2% to Rs.19878 Crore. Quarter to Quarter Revenue Surge by 11.4% and Q to Q Profit grown by 8.9%

00:00 / 03:57

JUBILANT PHARMOVA Sep 23 Revenue as compared to Sep,22 Zooms by 5.1% to Rs.1680 Crore and Year on Year Profit zooms by 1162.2% to Rs.62 Crore. Quarter to Quarter Revenue Zooms by 5.9% and Q to Q Profit spikes by 935.0%

00:00 / 04:24

Cipla Sep'23 Revenue as compared to Sep'22 Zooms by 14.6% to Rs.6678 Crore and Year on Year Profit zooms by 44.8% to Rs.1155 Crore. Quarter to Quarter Revenue Balloons by 16.4% and Q to Q Profit spikes by 121.4%

00:00 / 04:07

Maruti Suzuki Sep 23 Revenue as compared to Sep,22 Jumps by 23.8% to Rs.37073 Crore and Year on Year Profit flies by 78.2% to Rs.3764 Crore. Quarter to Quarter Revenue Surge by 14.6% and Q to Q Profit increases sharply by 49.1%

00:00 / 04:10
bottom of page